PerspectivePediatric Vaccines

Development of Newborn and Infant Vaccines

See allHide authors and affiliations

Science Translational Medicine  06 Jul 2011:
Vol. 3, Issue 90, pp. 90ps27
DOI: 10.1126/scitranslmed.3001880

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

  • The ideal vaccine for babies

    In 1989, when I visited California with my family, we had a lunch at McDonald’s in Santa Barbara. On the placemat on our tray there was an announcement from Mr. Grin on how parents should protect their children by having them vaccinated. It stated that at 18 months your child needs the Haemophilus influenzae type b (Hib) vaccine. At that time, this vaccine was a polysaccharide vaccine, which is not effective below 18 months. Ho...

    Show More
    Competing Interests: None declared.

Stay Connected to Science Translational Medicine